| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | INTREXON CORP | 61,724,682 | 2,800,449,000 | 78.80% | ||
| 2 | HALOZYME THERAPEUTICS INC | 19,816,162 | 282,975,000 | 7.96% | ||
| 3 | ZIOPHARM ONCOLOGY INC | 19,272,415 | 207,564,000 | 5.84% | ||
| 4 | FIBROCELL SCIENCE INC | 15,644,427 | 70,556,000 | 1.99% | ||
| 5 | ENTERPRISE PRODS PARTNERS L | 1,035,834 | 34,110,000 | 0.96% | ||
| 6 | SYNTHETIC BIOLOGICS INC | 12,300,768 | 26,939,000 | 0.76% | ||
| 7 | HISTOGENICS CORP | 2,690,570 | 26,879,000 | 0.76% | ||
| 8 | ENERGY TRANSFER L P | 376,200 | 23,836,000 | 0.67% | ||
| 9 | PLAINS ALL AMERN PIPELINE L | 400,000 | 19,508,000 | 0.55% | ||
| 10 | OVASCIENCE INC COM | 373,224 | 12,962,000 | 0.36% | ||
| 11 | GENESIS ENERGY LP COM UNITS NPV | 217,000 | 10,199,000 | 0.29% | ||
| 12 | ORAGENICS INC COM NEW | 9,839,221 | 10,036,000 | 0.28% | ||
| 13 | NUSTAR ENERGY LP | 116,500 | 7,072,000 | 0.20% | ||
| 14 | TC PIPELINES LP | 97,000 | 6,320,000 | 0.18% | ||
| 15 | MARTIN MIDSTREAM | 141,800 | 5,025,000 | 0.14% | ||
| 16 | REGENCY ENERGY PARTNERS | 188,250 | 4,305,000 | 0.12% | ||
| 17 | Crestwood Midstream Partners LP | 284,620 | 4,130,000 | 0.12% | ||
| 18 | TRANSGENOMIC INC | 770,490 | 1,110,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-15-016350, filed 2015.04.24).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
